摘要
全球大流行的新型冠状病毒肺炎(COVID-19)疫情引起了世界范围内的高度关注,而新型冠状病毒(SARS-CoV-2)的发源地至今仍未确定。在救治COVID-19患者的过程中,中医药发挥了重要作用。中国国家层面高度重视中医药参与COVID-19的防治作用,加强医疗救治工作中中医药的及早介入。中医药在病毒性肺炎的防治方面有其特色和优势,能收到较好临床疗效且副作用少,除能够消除或减轻、缓解临床症状外,还能够调节患者自身的免疫功能,防治病毒引起的机体免疫过度反应。针对中医药防治病毒性肺炎的免疫调节作用的研究进展进行综述,以期为包括COVID-19在内的病毒性肺炎的临床用药及后期基础研究提供一定参考。
The outbreak of a new type of coronavirus(SARS-Co V-2)pneumonia has been spreading all over the world,drawing worldwide attention.However,the origin of the novel coronavirus has not been determined yet.Traditional Chinese medicine played an important role in treating SARS-CoV-2 infection.The state attaches great importance to the role of TCM in the prevention and treatment of SARS-CoV-2 infection,and strengthens the early intervention of TCM in medical treatment.Traditional Chinese medicine has its own characteristics and advantages in the prevention and treatment of viral pneumonia,with better clinical efficacy and fewer side effects.In addition to eliminating or alleviating clinical symptoms,it can also regulate the immune function of patients and prevent the overreaction of the body caused by viruses.This article reviews the research on the immunomodulatory action of traditional Chinese medicine in the prevention and treatment of viral pneumonia,hoping to provide some reference for the clinical medication and later basic research of viral pneumonia including SARS-CoV-2.
作者
樊启猛
潘雪
贺玉婷
朱志飞
肖美凤
周晋
周逸群
邓凯文
孟蕾
贺福元
FAN Qi-meng;PAN Xue;HE Yu-ting;ZHU Zhi-fei;XIAO Mei-feng;ZHOU Jin;ZHOU Yi-qun;DENG Kai-wen;MENG Lei;HE Fu-yuan(College of Pharmacy,Hunan University of Chinese Medicine,Changsha 410208,China;Hunan Key Laboratory of Druggability and Preparation Modification of TCM,Changsha 410208,China;Piece Processing and Pharmaceutical Preparation Engineering Technological Laboratory of TCM,Hunan University of Chinese Medicine,Changsha 410208,China;The First Clinical Hospital of TCM,Hunan University of Chinese Medicine,Changsha 410007,China;Laboratory of Supramolecular Mechanism and Mathematic-Physics Characterization for Chinese Materia Medica,Hunan University of Chinese Medicine,Changsha 410208,China;Key Laboratory of Property and Pharmacodynamics of TCM,State Administration of Traditional Chinese Medicine,Changsha 410208,China)
出处
《中草药》
CAS
CSCD
北大核心
2020年第8期2065-2074,共10页
Chinese Traditional and Herbal Drugs
基金
国家自然科学基金项目(81573691)
国家自然科学基金项目(81874507)
湖南省教育厅创新平台开放基金项目(18K071)
长沙市科技计划项目(kq1907137)
湖南省研究生科研创新项目(CX20190570)
湖南中医药大学研究生科研创新课题(2018CX18)。
关键词
中医药基础理论
中药
新型冠状病毒
病毒性肺炎
传染病
细胞因子风暴
免疫调节
traditional Chinese medicine theory
Chinese materia medica
SARS-Co V-2
viral pneumonia
infectious disease
cytokines storm
immunoregulation
